Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 2
×
Myasthenia Gravis
×
30 days
×
Clear all
Filters
3
NCT06414954
2026-04-13
SYNAPSE-MG
NMD Pharma A/S
Phase 2
Recruiting
84 enrolled
NCT06987539
2026-04-07
THYME
Amgen
Phase 2
Recruiting
15 enrolled
NCT07501702
2026-03-30
ETNA
Vertex Pharmaceuticals Incorporated
Phase 2
Not yet recruiting
30 enrolled